{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:17:39Z","timestamp":1769509059125,"version":"3.49.0"},"reference-count":18,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2021,7,30]]},"DOI":"10.1536\/ihj.20-817","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T22:11:42Z","timestamp":1626473502000},"page":"752-755","source":"Crossref","is-referenced-by-count":8,"title":["Plasma Level of Elabela in Patients with Coronary Heart Disease and Its Correlation with the Disease Classification"],"prefix":"10.1536","volume":"62","author":[{"given":"Qing-Ping","family":"Tian","sequence":"first","affiliation":[{"name":"Department of Geriatrics, Peking University First Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Lin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Peking University First Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Rong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, School of Basic Medical Sciences, Peking University Health Science Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deng-Ren","family":"Ji","sequence":"additional","affiliation":[{"name":"Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, School of Basic Medical Sciences, Peking University Health Science Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Meng","family":"Liu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, School of Basic Medical Sciences, Peking University Health Science Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhao","sequence":"additional","affiliation":[{"name":"Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, School of Basic Medical Sciences, Peking University Health Science Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Fen","family":"Qi","sequence":"additional","affiliation":[{"name":"Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, School of Basic Medical Sciences, Peking University Health Science Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. O&apos;Dowd BF, Heiber M, Chan A, <i>et al<\/i>. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 1993; 136: 355-60.","DOI":"10.1016\/0378-1119(93)90495-O"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Liu W, Yan J, Pan W, Tang M. Apelin\/Elabela-APJ: a novel therapeutic target in the cardiovascular system. Ann Transl Med 2020; 8: 243.","DOI":"10.21037\/atm.2020.02.07"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ho L, van Dijk M, Chye STJ, <i>et al<\/i>. ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice. Science 2017; 357: 707-13.","DOI":"10.1126\/science.aam6607"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Tatemoto K, Hosoya M, Habata Y, <i>et al<\/i>. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998; 251: 471-6.","DOI":"10.1006\/bbrc.1998.9489"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Chng SC, Ho L, Tian J, Reversade B. ELABELA: a hormone essential for heart development signals via the apelin receptor. Dev Cell 2013; 27: 672-80.","DOI":"10.1016\/j.devcel.2013.11.002"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Pauli A, Norris ML, Valen E, <i>et al<\/i>. Toddler: an embryonic signal that promotes cell movement via apelin receptors. Science 2014; 343: 1248636.","DOI":"10.1126\/science.1248636"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Perj\u00e9s \u00c1, Kilpi\u00f6 T, Ulvila J, <i>et al<\/i>. Characterization of apela, a novel endogenous ligand of apelin receptor, in the adult heart. Basic Res Cardiol 2016; 111: 2.","DOI":"10.1007\/s00395-015-0521-6"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Xi Y, Yu D, Yang R, <i>et al<\/i>. Recombinant Fc-Elabela fusion protein has extended plasma half-life and mitigates post-infarct heart dysfunction in rats. Int J Cardiol 2019; 292: 180-7.","DOI":"10.1016\/j.ijcard.2019.04.089"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. D\u00f6nmez Y, Acele A. Increased elabela levels in the acute ST segment elevation myocardial infarction patients. Medicine (Baltimore) 2019; 98: e17645.","DOI":"10.1097\/MD.0000000000017645"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Wright RS, Anderson JL, Adams CD, <i>et al<\/i>. ACCF\/AHA focused update of the guidelines for the management of patients with unstable angina\/non-ST-elevation myocardial infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation 2011; 123: 2022-60.","DOI":"10.1161\/CIR.0b013e31820f2f3e"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Kuba K, Sato T, Imai Y, Yamaguchi T. Apelin and Elabela\/Toddler; double ligands for APJ\/Apelin receptor in heart development, physiology, and pathology. Peptides 2019; 111: 62-70.","DOI":"10.1016\/j.peptides.2018.04.011"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Li Y, Yang X, Ouyang S, <i>et al<\/i>. Declined circulating elabela levels in patients with essential hypertension and its association with impaired vascular function: a preliminary study. Clin Exp Hypertens 2020; 42: 239-43.","DOI":"10.1080\/10641963.2019.1619756"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Geng Z, Ye C, Tong Y, Zhang F, Zhou YB, Xiong XQ. Exacerbated pressor and sympathoexcitatory effects of central Elabela in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2020; 318: H124-34.","DOI":"10.1152\/ajpheart.00449.2019"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Schreiber CA, Holditch SJ, Generous A, Ikeda Y. Sustained ELABELA gene therapy in high-salt diet-induced hypertensive rats. Curr Gene Ther 2017; 16: 349-60.","DOI":"10.2174\/1566523217666161121111906"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Xu C. The Elabela in hypertension, cardiovascular disease, renal disease, and preeclampsia: an update. J Hypertens 2021; 39: 12-22.","DOI":"10.1097\/HJH.0000000000002591"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Zhang Y, Wang Y, Lou Y, <i>et al<\/i>. Elabela, a newly discovered APJ ligand: similarities and differences with apelin. Peptides 2018; 109: 23-32.","DOI":"10.1016\/j.peptides.2018.09.006"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Rakhshan K, Azizi Y, Naderi N, Afousi AG, Aboutaleb N. ELABELA (ELA) peptide exerts cardioprotection against myocardial infarction by targeting oxidative stress and the improvement of heart function. Int J Pept Res Ther 2019; 25: 613-21.","DOI":"10.1007\/s10989-018-9707-8"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Yang P, Read C, Kuc RE, <i>et al<\/i>. Elabela\/Toddler is an endogenous agonist of the apelin APJ receptor in the adult cardiovascular system, and exogenous administration of the peptide compensates for the downregulation of its expression in pulmonary arterial hypertension. Circulation 2017; 135: 1160-73.","DOI":"10.1161\/CIRCULATIONAHA.116.023218"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/4\/62_20-817\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T04:06:31Z","timestamp":1627704391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/4\/62_20-817\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,30]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.20-817","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,30]]},"article-number":"20-817"}}